YSB Inc.
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDocto… Read more
YSB Inc. (B1S) - Total Liabilities
Latest total liabilities as of June 2025: €4.50 Billion EUR
Based on the latest financial reports, YSB Inc. (B1S) has total liabilities worth €4.50 Billion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
YSB Inc. - Total Liabilities Trend (2021–2024)
This chart illustrates how YSB Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
YSB Inc. Competitors by Total Liabilities
The table below lists competitors of YSB Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gaming Innovation Group Inc
OL:GIG
|
Norway | Nkr188.02 Million |
|
ElringKlinger AG
PINK:EGKLF
|
USA | $1.22 Billion |
|
Lict Corporation
PINK:LICT
|
USA | $140.84 Million |
|
PetroVietnam General Services Corp
VN:PET
|
Vietnam | ₫10.90 Trillion |
|
Dong-A St
KO:170900
|
Korea | ₩747.62 Billion |
|
Ramkhamhaeng Hospital Public Company Limited
BK:RAM
|
Thailand | ฿22.65 Billion |
|
BioInvent International AB (publ)
PINK:BOVNF
|
USA | $102.10 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down YSB Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.93 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how YSB Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for YSB Inc. (2021–2024)
The table below shows the annual total liabilities of YSB Inc. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €4.23 Billion | +26.99% |
| 2023-12-31 | €3.33 Billion | -60.74% |
| 2022-12-31 | €8.48 Billion | +33.62% |
| 2021-12-31 | €6.35 Billion | -- |